$263 Million is the total value of ARMISTICE CAPITAL, LLC's 46 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 111.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | SPDR S&P 500 ETF TRput | $37,706,000 | -34.5% | 180,000 | -35.7% | 14.36% | -36.4% | |
| ATRS | Buy | ANTARES PHARMA INC | $16,202,000 | +20.9% | 15,430,000 | +0.2% | 6.17% | +17.2% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $8,952,000 | -33.1% | 800,000 | -50.0% | 3.41% | -35.1% |
| ARLZ | New | ARALEZ PHARMACEUTICALS INC | $8,791,000 | – | 2,664,000 | +100.0% | 3.35% | – |
| TLRDQ | Buy | TAILORED BRANDS INC | $8,710,000 | +21.6% | 688,000 | +72.0% | 3.32% | +18.0% |
| RXDX | Sell | IGNYTA INC | $8,434,000 | -26.2% | 1,556,000 | -7.8% | 3.21% | -28.4% |
| TPX | New | TEMPUR SEALY INTL INC | $7,966,000 | – | 144,000 | +100.0% | 3.03% | – |
| BWLD | Buy | BUFFALO WILD WINGS INC | $7,781,000 | +64.2% | 56,000 | +75.0% | 2.96% | +59.2% |
| HAIN | Sell | HAIN CELESTIAL GROUP INC | $7,562,000 | -17.5% | 152,000 | -32.1% | 2.88% | -20.0% |
| New | HAIN CELESTIAL GROUP INCcall | $7,463,000 | – | 150,000 | +100.0% | 2.84% | – | |
| LVS | Buy | LAS VEGAS SANDS CORP | $7,132,000 | +11.3% | 164,000 | +32.3% | 2.72% | +8.0% |
| FRPT | Sell | FRESHPET INC | $6,998,000 | -30.4% | 750,000 | -45.3% | 2.66% | -32.5% |
| HZNP | New | HORIZON PHARMA PLC | $6,588,000 | – | 400,000 | +100.0% | 2.51% | – |
| NOMD | Buy | NOMAD HLDGS LTD | $6,384,000 | +24.7% | 800,000 | +40.8% | 2.43% | +21.0% |
| THC | New | TENET HEALTHCARE CORP | $6,302,000 | – | 228,000 | +100.0% | 2.40% | – |
| BDSI | Sell | BIODELIVERY SCIENCES | $6,259,000 | -28.6% | 2,652,000 | -2.2% | 2.38% | -30.7% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $5,917,000 | -37.5% | 232,000 | -35.2% | 2.25% | -39.4% |
| SNY | New | SANOFIsponsored adr | $5,775,000 | – | 138,000 | +100.0% | 2.20% | – |
| DECK | Buy | DECKERS OUTDOOR CORP | $5,752,000 | +60.0% | 100,000 | +66.7% | 2.19% | +55.2% |
| KATE | Buy | KATE SPADE & CO | $5,317,000 | -7.0% | 258,000 | +15.2% | 2.02% | -9.8% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $5,292,000 | – | 240,000 | +100.0% | 2.02% | – |
| BCOR | Sell | BLUCORA INC | $5,180,000 | -47.4% | 500,000 | -73.8% | 1.97% | -49.0% |
| SGYPQ | Sell | SYNERGY PHARMACEUTICALS DEL | $5,054,000 | -16.8% | 1,330,000 | -39.5% | 1.92% | -19.3% |
| New | PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $4,834,000 | – | 22,760,000 | +100.0% | 1.84% | – | |
| New | VALEANT PHARMACEUTICALS INTLcall | $4,834,000 | – | 240,000 | +100.0% | 1.84% | – | |
| TTWO | Sell | TAKE-TWO INTERACTIVE SOFTWAR | $4,550,000 | -2.6% | 120,000 | -3.2% | 1.73% | -5.5% |
| BLUE | New | BLUEBIRD BIO INC | $4,156,000 | – | 96,000 | +100.0% | 1.58% | – |
| NILE | New | BLUE NILE INC | $4,052,000 | – | 148,000 | +100.0% | 1.54% | – |
| PZZA | New | PAPA JOHNS INTL INC | $3,944,000 | – | 58,000 | +100.0% | 1.50% | – |
| DFRG | New | DEL FRISCOS RESTAURANT GROUP | $3,895,000 | – | 272,000 | +100.0% | 1.48% | – |
| HABT | New | HABIT RESTAURANTS INC | $3,866,000 | – | 236,000 | +100.0% | 1.47% | – |
| FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $3,738,000 | – | 348,003 | +100.0% | 1.42% | – |
| DMD | Sell | DEMAND MEDIA INC | $3,722,000 | -32.1% | 720,000 | -34.3% | 1.42% | -34.1% |
| RH | New | RESTORATION HARDWARE HLDGS I | $3,671,000 | – | 128,000 | +100.0% | 1.40% | – |
| RRR | New | RED ROCK RESORTS INCcl a | $3,473,000 | – | 158,000 | +100.0% | 1.32% | – |
| LB | New | L BRANDS INC | $3,357,000 | – | 50,000 | +100.0% | 1.28% | – |
| TENX | Sell | TENAX THERAPEUTICS INC | $2,842,000 | +18.5% | 1,110,000 | -5.1% | 1.08% | +14.9% |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $2,073,000 | – | 482,073 | +100.0% | 0.79% | – |
| QLTI | New | QLT INC | $1,556,000 | – | 1,095,455 | +100.0% | 0.59% | – |
| SCYX | New | SCYNEXIS INC | $1,515,000 | – | 698,000 | +100.0% | 0.58% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $1,420,000 | – | 408,000 | +100.0% | 0.54% | – |
| LPCN | New | LIPOCINE INC NEW | $1,216,000 | – | 400,000 | +100.0% | 0.46% | – |
| AEGR | Sell | AEGERION PHARMACEUTICALS INC | $1,192,000 | -78.5% | 800,000 | -46.6% | 0.45% | -79.1% |
| MDGS | Sell | MEDIGUS LTDsponsored adr | $625,000 | -44.6% | 618,600 | -0.2% | 0.24% | -46.3% |
| New | OFFICE DEPOT INCcall | $463,000 | – | 139,900 | +100.0% | 0.18% | – | |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $156,000 | – | 600,000 | +100.0% | 0.06% | – |
| PTX | Exit | PERNIX THERAPEUTICS HLDGS IN | $0 | – | -582,000 | -100.0% | -0.24% | – |
| KODK | Exit | EASTMAN KODAK CO | $0 | – | -78,000 | -100.0% | -0.33% | – |
| SEAS | Exit | SEAWORLD ENTMT INC | $0 | – | -56,000 | -100.0% | -0.46% | – |
| RLOC | Exit | REACHLOCAL INC | $0 | – | -925,000 | -100.0% | -0.65% | – |
| EXPR | Exit | EXPRESS INC | $0 | – | -108,000 | -100.0% | -0.91% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $0 | – | -6,300,000 | -100.0% | -0.98% | – | |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -172,000 | -100.0% | -0.98% | – |
| CHEF | Exit | CHEFS WHSE INC | $0 | – | -176,000 | -100.0% | -1.40% | – |
| PLAY | Exit | DAVE & BUSTERS ENTMT INC | $0 | – | -98,000 | -100.0% | -1.49% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -2,000,000 | -100.0% | -2.32% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -400,000 | -100.0% | -2.95% | – |
| HWAY | Exit | HEALTHWAYS INC | $0 | – | -840,000 | -100.0% | -3.33% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -2,846,000 | -100.0% | -5.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.